In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange? Alexandre Soares Ferreira Junior, Kate Sanborn, Morgana Pinheiro Maux Lessa, Alexander Gordee, Maragatha Kuchibhatla, Allison O. Taylor, Matthew S. Karafin, Oluwatoyosi A. Onwuemene

Outcomes of thrombotic thrombocytopenic purpura patients submitted to therapeutic plasma exchange in a single center in Brazil Patrícia Oliveira Cunha Terra, Gil Cunha De Santis, Benedito de Pina Almeida Prado Júnior, Luciana Correa Oliveira

LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY Özgür Pektaş, Marie Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knöbl, Flora Peyvandi, Spero Cataland, Paul Coppo, Johanna A. Kremer Hovinga, Jessica Minkue Mi Edou, Rui de Passos Sousa, Sriya Gunawardena, Julie Lin